Vital Infrastructure Property Trust (VITL.UN) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
New CEO Zach Vaughan, appointed July 2025, brings international real estate experience and emphasizes disciplined capital allocation and strategic asset management.
The REIT's global healthcare infrastructure portfolio remains defensive, with high occupancy, long lease terms, and stable, inflation-indexed cash flows.
Q2 2025 saw operational momentum with improved AFFO per unit, a lower payout ratio, and over $282 million in non-core asset sales year to date.
The distribution reinvestment plan (DRIP) was suspended to optimize capital structure and focus on NAV growth.
Financial highlights
Q2 consolidated same-property NOI was $73.2 million, up 2.8% year-over-year, with all regions contributing positively.
AFFO per unit was $0.10, up 19% year-over-year, with an AFFO payout ratio of 88% versus 105% a year ago.
Net income for Q2 2025 was $32.6 million, reversing a net loss of $127.2 million in Q2 2024, driven by lower interest expense, fair value gains, and FX gains.
Interest expense decreased to $30.8 million from $53.8 million year-over-year, reflecting debt reduction and lower rates.
Net fair value gains of approximately $14 million were recorded, driven by improved NOI and valuations in Europe and Australasia.
Outlook and guidance
Management expects G&A cost ratio to normalize to 5.5% by year-end as efficiency initiatives take hold.
Same-property NOI growth in the 2%-3% range is targeted for most regions, with Brazil higher due to inflation.
Healthscope rent deferral arrangements expected to be repaid by March 31, 2026, or upon asset sale completion.
Ongoing focus on debt reduction, refinancing, and prudent payout ratios aligned with 80%-90% target.
Continued emphasis on asset sales, operational simplification, and maximizing unitholder value.
Latest events from Vital Infrastructure Property Trust
- FFO and AFFO per unit rose, leverage fell, and major asset sales drove North American focus.VITL.UN
Q4 202525 Feb 2026 - Major asset sales and strong operations drive deleveraging and position for improved earnings.VITL.UN
Q2 20241 Feb 2026 - Asset sales, refinancing, and high occupancy drive lower leverage and set up a 2025 turnaround.VITL.UN
Q3 202413 Jan 2026 - AFFO per unit up 15%, leverage down, and over $260M in asset sales boosted liquidity.VITL.UN
Q1 20255 Jan 2026 - AFFO per unit up to 15%, leverage down, and investment-grade rating achieved in Q4 2024.VITL.UN
Q4 202425 Dec 2025 - Q3 2025 saw strong results, higher AFFO, and major progress on Vital Trust internalization.VITL.UN
Q3 202515 Nov 2025